Levodopa motor complications in Parkinson's disease
- PMID: 11052214
- DOI: 10.1016/s1471-1931(00)00031-8
Levodopa motor complications in Parkinson's disease
Abstract
Parkinson's disease (PD) is an age-related neurodegenerative disorder with an average onset age of 60 years. In the United States, approximately one million persons suffer from PD, and there are 60,000 newly diagnosed cases every year. The estimated cost of PD to society is $27 billion per year. Based on United States Census Bureau projections, it is estimated that the frequency of PD will increase fourfold by the year 2040, making it an even larger burden on patients, their families and society.
Similar articles
-
[Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease].Rev Neurol. 1999 May 1-15;28(9):889-98. Rev Neurol. 1999. PMID: 10390756 Review. Spanish.
-
Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease.Curr Opin Neurol. 2003 Dec;16 Suppl 1:S3-7. doi: 10.1097/00019052-200312001-00002. Curr Opin Neurol. 2003. PMID: 15180131 Review.
-
Continuous dopamine-receptor stimulation in early Parkinson's disease.Trends Neurosci. 2000 Oct;23(10 Suppl):S117-26. doi: 10.1016/s1471-1931(00)00030-6. Trends Neurosci. 2000. PMID: 11052229 Review.
-
Levodopa in the treatment of Parkinson's disease: current controversies.Mov Disord. 2004 Sep;19(9):997-1005. doi: 10.1002/mds.20243. Mov Disord. 2004. PMID: 15372588 Review.
-
Levodopa-dyskinesia incidence by age of Parkinson's disease onset.Mov Disord. 2005 Mar;20(3):342-4. doi: 10.1002/mds.20360. Mov Disord. 2005. PMID: 15580606
Cited by
-
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10. Brain. 2015. PMID: 25669730 Free PMC article. Clinical Trial.
-
Clinical applications of neurochemical and electrophysiological measurements for closed-loop neurostimulation.Neurosurg Focus. 2020 Jul;49(1):E6. doi: 10.3171/2020.4.FOCUS20167. Neurosurg Focus. 2020. PMID: 32610297 Free PMC article.
-
Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14. Neurodegener Dis Manag. 2019. PMID: 30547712 Free PMC article.
-
Closing the loop for patients with Parkinson disease: where are we?Nat Rev Neurol. 2022 Aug;18(8):497-507. doi: 10.1038/s41582-022-00674-1. Epub 2022 Jun 9. Nat Rev Neurol. 2022. PMID: 35681103 Review.
-
Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research awardees.Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17693-5. doi: 10.1073/pnas.1419249111. Epub 2014 Dec 8. Proc Natl Acad Sci U S A. 2014. PMID: 25489082 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical